Next-Gen HCP Analysis in Biopharma

Discover how LC-MS is advancing biopharma workflows through scalable, high-throughput proteomics. This webinar will highlight recent developments in LC-MS-based approaches, including HCP analysis, untargeted quantification strategies, and scalable sample preparation, with a focus on robustness, reproducibility, and applicability in both research and regulated quality control environments.

Prospective ICH Q2(R2)-aligned total-error validation of label-free untargeted proteomics for host cell protein quantification in biotherapeutics

• Somar khalil, PhD, Principal Scientist, Analytical research & Development, GSK

Abstract to be announced